Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells. - Wikidata - wikimedia - TriplyDB

Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.

Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.

http://www.wikidata.org/entity/Q33576337

about

The lipidome and proteome of oil bodies from Helianthus annuus (common sunflower)Choline metabolism-based molecular diagnosis of cancer: an update Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer Silicon particles as trojan horses for potential cancer therapy.Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.The biology and synthesis of α-hydroxytropolones.Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.Choline metabolism in malignant transformation.Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation Chaperone gp96 mediates ER-α36 cell membrane expression.Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.Expression of HER2 in Breast Cancer Promotes a Massive Reorganization of Gene Activity and Suggests a Role for Epigenetic Regulation Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells Mitogenic effects of phosphatidylcholine nanoparticles on MCF-7 breast cancer cells.MR evaluation of response to targeted treatment in cancer cells.MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.Chemical modulation of glycerolipid signaling and metabolic pathways.The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer.Targeting Phospholipid Metabolism in Cancer.V-ATPase inhibition overcomes trastuzumab resistance in breast cancer.Nuclear phosphoinositide regulation of chromatin.Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation.Design and synthesis of phospholipase C and A2-activatable near-infrared fluorescent smart probes.Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model.Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging.Mek activity is required for ErbB2 expression in breast cancer cells detached from the extracellular matrix.Metabolic Footprints and Molecular Subtypes in Breast Cancer.Development and Analytical Validation of a BT-474 Anti-Proliferation Assay Targeting HER2

P2860

Q24599626-E7F396EC-39AD-482C-8F43-840D6C880DD2 Q27024079-D45DF550-C542-4A77-9CB0-B231A35A6E94 Q28074613-7954DAA7-77A2-4A63-9D59-211D508B3C8A Q30412166-50C1ED01-B5E8-472A-BA15-87417AB5D73D Q33580152-4A9B4C38-7121-47D0-8961-0A2756BFA7D0 Q33968209-9639474D-F1E5-4EF8-AB66-77CBB87284B6 Q34201606-49CEF521-2A93-4C81-933B-9A04620DA111 Q35112040-4C5C8F28-FC6D-4017-BD8B-4E87CD9D7DC9 Q35786713-0A6BAE3F-9188-41DF-9004-821300D628DA Q35899955-C8F6D0F4-8D5F-4074-B1F4-485F8EFBA957 Q36544709-24AF4853-416D-4BE5-98AF-9118C1993656 Q36926125-0C6C52EC-5FF4-4872-A6B5-3E78F1832205 Q37141830-9FB9BCE9-AD19-4DCE-A045-883DAA985F98 Q37260499-D3FA236C-B350-4FA1-B8B0-0DBEDED42AD0 Q37559012-BA01CB6C-0362-458E-BB94-262F2E25C30E Q37638795-D2927DAC-3DD1-4B03-8567-325291338C89 Q37688019-340CB248-DEFF-4DF0-A432-E7929B0104AA Q37851076-EB9CDA53-611D-4151-95DC-68FA7E226D08 Q37906482-98D88F4B-6E8E-42A4-8C3D-397EC9DEFE39 Q37958637-07A8F69F-3B4F-4F92-BC4D-3A29C60ED013 Q38179801-CCD897E9-BFF5-44C3-87CC-9995A48BA12C Q38302045-45D4015A-1CDE-4743-B673-12D7C4F0FEE0 Q38924681-B4735635-D11F-41B3-A65E-A2CF6C05E5B0 Q39084885-9DF2218F-19B2-4CD0-8971-D0B05E56C5C7 Q39093549-485D5B3F-DF08-4CB5-832D-256D0222D38A Q39159757-31A4DCE6-7AA6-4AD9-AF01-9E8F6A05D26B Q39404690-C5FF58E8-205F-4392-B950-377662B15BD4 Q39832315-4A388F68-D88A-4AC4-AD4D-8C21892A26E4 Q40572969-5161CEF6-2E5D-4027-A1EA-36110F0223F5 Q41549845-1BF0F5F0-E794-4BCA-993F-BE703BFFA842 Q42207993-27C317E9-1E6D-49B8-96EE-2266B10C0D7F Q42358657-B9811970-B4B6-4618-B305-0063CCC463A3 Q47102400-A3717CBE-4266-4231-BBC3-08B7529E70DA Q49871101-FF465922-0516-4212-9B60-A9EAD59D3CDC Q58126050-00AF1DC4-039F-4A7E-A5E7-15A53C5C1205

P2860

Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.

http://www.wikidata.org/entity/Q33576337

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@ast

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@en

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@nl

type

label

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@ast

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@en

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@nl

prefLabel

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@ast

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@en

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@nl

P1433

Q33576337-A038BB47-85E0-49A3-9C9A-DA76D74781F6

P1476

Q33576337-B69420A9-26EE-4521-BA29-7F84720042F8

P2093

Q33576337-10B8028B-239E-41B4-BC39-DA07B5AD6A78

Q33576337-2D210729-6B7B-47F6-9889-B5874E8CDD82

Q33576337-46AC396F-AB03-40BF-ADDD-E3AA5DC344B6

Q33576337-5C155C16-182E-4EDE-9318-7A239AB6D725

Q33576337-5E4C6CD0-3A84-45CD-8F61-4F8C2778431C

Q33576337-99337270-32EA-4758-B637-DC202C3CD3EB

Q33576337-C14DC9E0-23AF-447D-BDDB-9F8AF7A58A00

P2860

Q33576337-01F6401D-B980-4C45-8F61-C02184EB6684

Q33576337-08D162EF-E5A1-4CDF-8821-B80EF7DABE24

Q33576337-0D2A38C0-869C-4949-A34D-22FF1A4064EC

Q33576337-162AAEFD-44DE-4219-90A6-1CBB91219B0D

Q33576337-192F7002-A849-4D95-A3FF-1A61697E2745

Q33576337-257FB6C1-60EA-42A1-8174-93B6205EEEF0

Q33576337-27BD07C7-41B7-4B76-B79A-8F26D833FB0A

Q33576337-28ADCB83-D5B2-4461-8E6D-1D5947C22349

Q33576337-2AEEDCBB-0526-4305-A340-C04C40405A0F

Q33576337-2F1A5012-9E37-4E5B-83F9-72FE50E6BF29

P2888

Q33576337-B4CB06E0-C433-4260-AE90-AA24212DE6A8

P304

Q33576337-A0C771C4-9E2C-4714-A086-D63498AB7285

P31

Q33576337-52314423-CDD1-4634-B4EF-388CC8B8B706

P356

Q33576337-A05D89FF-6ECF-46C7-8EC0-C20D0A26D134

P433

Q33576337-E896F156-6018-4BA0-8C61-74CD31B336CE

P478

Q33576337-CEAD8345-D23B-43D8-AE1C-6DBB919C7171

P50

Q33576337-40193416-D321-4BCC-8ADF-C89D780A2229

Q33576337-4B5F4A28-38EC-4C52-9F45-3086A3DD755A

Q33576337-60F508EA-3082-4086-84C0-21A45EC51B9D

P577

Q33576337-56AFC4D4-7161-4D65-86B4-63021188E2B0

P5875

Q33576337-291E8B6D-8C0A-4030-9644-4F924057B9A2

P6179

Q33576337-E1C57082-12E1-49F1-93BB-E12FE23F1D0E

P698

Q33576337-DB9C1A14-AE12-44D1-8E4D-97C4BD194CD0

P921

Q33576337-CA9D2281-87F3-48A7-92F0-F79E1BFCECEB

Q33576337-F4C1D97D-B2E5-40DC-B52C-A7411367304D

P932

Q33576337-9D8B0AB5-B944-4758-906D-94BB70C44DFA

P356

P1433

Breast Cancer Research

P1476

Inhibition of phosphatidylchol ...... mbrane of breast cancer cells.

@en

P2093

Carlo Ramoni

http://www.w3.org/2001/XMLSchema#string

Franca Podo

http://www.w3.org/2001/XMLSchema#string

Laura Abalsamo

http://www.w3.org/2001/XMLSchema#string

Luisa Paris

http://www.w3.org/2001/XMLSchema#string

Maria Elena Pisanu

http://www.w3.org/2001/XMLSchema#string

Pier Giorgio Natali

http://www.w3.org/2001/XMLSchema#string

Serena Cecchetti

http://www.w3.org/2001/XMLSchema#string

P2860

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Untangling the ErbB signalling network

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility

Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425

A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells

HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

P2888

P304

R27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2575

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Spadaro

P577

2010-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44592081

http://www.w3.org/2001/XMLSchema#string

P6179

1035497600

http://www.w3.org/2001/XMLSchema#string

P698

20462431

http://www.w3.org/2001/XMLSchema#string

P921

phosphatidylcholines

P932

2917016

http://www.w3.org/2001/XMLSchema#string